BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33465556)

  • 21. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
    Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
    Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3 Targets
    Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X
    Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
    Lei W; Vekariya RH; Ananthan S; Streicher JM
    J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
    Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
    Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
    Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
    J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 27-Hydroxycholesterol-induced EndMT acts
    Jiao K; Zhen J; Wu M; Teng M; Yang K; Zhou Q; Hu C; Zhou M; Li Y; Li Z
    Cancer Biol Med; 2020 Feb; 17(1):88-100. PubMed ID: 32296578
    [No Abstract]   [Full Text] [Related]  

  • 30. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.
    Cheng GZ; Zhang WZ; Sun M; Wang Q; Coppola D; Mansour M; Xu LM; Costanzo C; Cheng JQ; Wang LH
    J Biol Chem; 2008 May; 283(21):14665-73. PubMed ID: 18353781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
    Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
    Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
    Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
    Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
    Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer.
    Uddin N; Kim RK; Yoo KC; Kim YH; Cui YH; Kim IG; Suh Y; Lee SJ
    Cancer Sci; 2015 Jun; 106(6):718-725. PubMed ID: 25854938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
    Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
    Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment.
    Cheng M; Liu P; Xu LX
    J Inorg Biochem; 2020 Sep; 210():111159. PubMed ID: 32652260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice.
    Alongkronrusmee D; Chiang T; van Rijn RM
    Drug Alcohol Depend; 2016 Oct; 167():190-8. PubMed ID: 27567436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.